BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115

Name: BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115
Published: 2012
License: Public Domain

GlaxoSmithKline · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

continuation efficacy extension systemic-lupus-erythematosus

systemic lupus erythematosus, selena, belimumab, lupus, pga, blys, sle flare index, continuation, phase iii, bilag, extension, efficacy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 812366
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.